RTN, any thoughts on this after the news of share reversal? Are you still holding it? Thanks

read_this_n0w: any concerns SCON might get delisted?

Thanks Investor100.

Investor100, Thanks for posting this. I see the previous insider buys prior to February 2012 was in May 2007. Do they have any upcoming catalysts?

741k shares purchased for $233k by 7 insiders.

OXGN: AH ($1.24) reports final results from PH2 FALCON study
"Combination Regimen Well-Tolerated With No Significant Cumulative Toxicities"

OXGN - up 18% today

ALXA (1.10) : anybody knows what caused ALXA to jump from 1.03 to 1.18 suddenly? Anybody thinks 1.03 is the bottom and it is upward from now on? Thanks

icucTrader: What's your target on CLSN?

Curis Announces Presentation of Positive Vismodegib Pivotal Clinical Data in Advanced Basal Cell Carcinoma

http://www.marketwatch.com/story/curis-announces-presentation-of-positive-vismodegib-pivotal-clinical-data-in-advanced-basal-cell-carcinoma-2011-06-20?reflink=MW_news_stmp

FCSC (1.10) looks good this morning.

Thanks much hpham10.

FCSC ... Anybody knows what time the share holders meeting is going to be tomorrow for FCSC ?

FCSC ... $heff, I just want to ask you if you are going to stick to your usual plan of selling half of your holding before June 22nd? I'm wondering as I see that you are looking to add more if the chance comes. Thanks in advance.

OPTR. I put an order at 11.01. This is kind of low but you never know it may happen. Good luck to all especially my friend who are heavy ?

OPTR. Just wondering, how low you think it would go if it gets bear raided?

FCSC - Thanks Wrinkles for the chart and the reply. I agree that this will be another great Sheff Pick.
I hope that one of the chartests in the board can look into the chart and tell us what he thinks.

Thanks board for a great year so far!

Wrinkles, I am not a chartest so do you think from the chart you posted, FCSC is ready for the next run? Thanks for your posts!

NEOP - Colorofmoney, what do you think of the AH action in NEOP?? it is not reflecting the good news that was published today!

NEOP - AH action is making me scratch my head. Any idea?????

NEOP (4.56) Went as low as $4.10 on what it looks like a Bear raid before the news tomorrow.

NEOP ($4.25).... It is falling fast, any idea what is happening?

SPPI - Congrats to all holders. Great job.

That was around my guess as well ($12-$13). I am wondering if any analysts are giving a target.

Thanks for the reply.

SPPI ... Anybody has any idea of what the target price will be if SPPI gets approval tomorrow? The clock is ticking.

GLTA

Thanks Sheff for the insight ... Will hold tight :)

AMRN ... Anybody knows why AMRN is drifting lower everyday??? Any news that the big players know and we dont know?

Thanks

Hi Sheff,

Please execuse my ignorance when it comes to options but does this unusual options activity mean the price might go up or down?

Thanks

$heff, What are your thoughts for PPS if PLX gets approved?

Thanks
Ariki

$heff and nsomniyak ..... thanks for the insight. Looks like you are right since the price went up about 0.10 since i posted the question. Will watch it closley as well. Thanks again

$heff, what are your thoughts about AVNR after laushing thier product? there seem to be no reaction from the market! do you think people are waiting for the quarterly call? do you think people are busy with DEPO now and ignoring everything else?

Thanks in advance.

Any thoughts on the PPS if this gets approved?

Thanks
Ariki

Smitter,

This is the A/S though not O/S. I have read somewhere in this board that some folks spoke to the CEO and they were assured no dilution will take place. I can't remember why the increase in A/S at the moment. I think Sterv posted some details on that if I am not mistaken. I agree it is scary with 20 Bil A/S, but I kinda tend to believe the CEO will not dilute. We'll see what happens.

BTW, I had my order at 0016.

GLTA
Ariki

Hey Folks,

Where do you see the PPS here? I have been watching this since it was .47 but hesitant to buy because of the lawsuits filed against SNG. Your comments is greatly appreciated.

Ariki

I didn't get MCLN, is it too late to jump in? Looks like the party is about to begin from this article biomedreports.com:



Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
We have been keeping an eye on this stock for a little over 3 weeks. Last week, just as it
emerged from sub-penny trading levels, we finally reached out to the management team and
interviewed them at length about their plans, expectations and current limitations. After an inital
lengthy discussion with them, we feel confident that our readers will like this company for many
of the same reasons that initially caught our eye.
MedClean Technologies, Inc. (OTC: MCLN) engages in the design, sale, installation, and
servicing of onsite turnkey systems to treat regulated medical waste. It provides MedClean
systems to hospitals and clinics as a solution to incineration or off site hauling of untreated
medical waste. The company?s MedClean system employs various equipment and machinery,
including an autoclave vessel to sterilize the medical waste; a shredding device, the MedClean
Shredder, to convert sterilized waste material into confetti-like material qualifying the end
product as municipal solid waste (See the comprehensive video on the right).
We believe the product is a game changer in the Regulated Medical Waste space and it has
already begun saving hospitals and clinics millions of dollars by affecting not only how they
handle the often times hazardous waste material, but also in regulatory compliance fees and
reporting requirements.
As we mentioned earlier this weekend, we feel that the potential moves for this equity will make
our now infamous BioElectronics (OTC:BIEL) pick look like child's play. Some of you may
recall that we did help call attention to BIEL's technology at the sub penny level before it moved
to $.12 before stalling and becoming a "buy on rumor sell on news" penny stock. Things may
1 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
change for BIEL if they ever finally get their FDA approval, but even then, the billion shares of
trading float have become a huge anchor to the stock.
Investors who invested in American Scientific Resources, Inc's (Pink Sheets: ASFX) FDA
approved home needle destruction device, the Disintegrator(TM) and Disintegrator Plus(TM)
should also get very excited about this medical waste play. ASFX.PK ran from .003 to .08 based
on a needle dispenser (one product) called the Disintegrator. They traded millions of shares
churning through the shares to get that to the .08 level w/o the transparency of the share
structure.
Another one of our recently profiled companies, Viking Systems, Inc. (OTCBB:VKNG)
recently ran from $.003 to $1.10 on news regarding a contract with the U.S. Army
over a period of four days.
VKNG also appeared on the SEC's
Regulation SHO
compliance tool list (like MCLN does today [more on that below]).
MedClean Technologies, Inc. (OTC: MCLN) looks more bullish and attractive to small cap
investors than any of these other companies, but don't take our word for it. Look at the chart.
Our published report on the company Tuesday will mark the first time any publication or news
portal will call attention to the company and their product. The management team does not
believe in hiring penny-stock pumpers and promoters an have never one so. This will be the first
comprehensive report on the company with quotes and information from the actual
management team.
Here are just a few of the bullet points that will be discussed in more detail in our special report
on Tuesday morning:
- MCLN's stock has just emerged from the sub-penny trading level and our own short-term
trading target of $.40
is based on our own in-depth technical, fundamental and financial analysis of the company.
A six month trading target of $1+ is very much possible
, but not likely sustainable without future growth and reported income variables which may or
may not be part of the company's immediate plans.
2 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
- MCLN has been on the SEC's Regulation SHO compliance tool list for 19 consecutive
days and is now
high on the market maker's
"buyin imminent" list
. In our opinion, continued volume will force the market makers to cover and help fuel prices
during the next 48-72 hours- exploding higher as demand exceeds supply.
- In 2008, MCLN posted a loss of 7.8 million and in the 3rd qrtr of 2009 they were cash flow
positive on an EBIDTA basis. Third Quarter Revenue Increases 108% Year-Over-Year.
- MCLN was recently awared a substantial MedAssets Supply Chain Systems Contract. M
edAssets (Nasdaq: MDAS)
trades at over $23 per share and they partner with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue cycle solutions.
MedAssets serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute
carehealthcare providers.
- Thanks to orders from hospitals and clinics like those, MCLN's management team has
informed us that they are running at full capacity and still experiencing an accumulation of
unfilled orders.
- MCLN's management team helped take their previous company to the NASDAQ and they
identified and protected intellectual property w/ patent application entitled “Containerized
Medical Waste Treatment System and Related Method.” The group previously worked together
at eResearchTechnology, Inc- where they helped grow the company's market valuation from
$27 million to a peak of $1.5 billion, receiving recognition from Fortune Magazine as the number
two fastest growing company in America. They recognized a fantastic new market opportunity
with MCLN and are building that vision now.
While we certainly hope you get as excited as we are about MCLN, we urge you to do your own
research and wish you only the best in your trading and investing.
This report is intended for paid subscribers of BioMedReports. Paid subscriptions are what
monetize BioMedReports, so please be aware that any unauthorized dissemination, review,
distribution or copying of this report is strictly prohibited. We will work with the owners of public
3 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
forums or websites where this information is posted without permission to provide us with the IP
address an/or identity of any individuals who post this or any other subscription based
information from this site.
Disclosure: Long MCLN

PMLG, here is a report from Biomedreports.com posted last nigt about MCLN.

Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
We have been keeping an eye on this stock for a little over 3 weeks. Last week, just as it
emerged from sub-penny trading levels, we finally reached out to the management team and
interviewed them at length about their plans, expectations and current limitations. After an inital
lengthy discussion with them, we feel confident that our readers will like this company for many
of the same reasons that initially caught our eye.
MedClean Technologies, Inc. (OTC: MCLN) engages in the design, sale, installation, and
servicing of onsite turnkey systems to treat regulated medical waste. It provides MedClean
systems to hospitals and clinics as a solution to incineration or off site hauling of untreated
medical waste. The company?s MedClean system employs various equipment and machinery,
including an autoclave vessel to sterilize the medical waste; a shredding device, the MedClean
Shredder, to convert sterilized waste material into confetti-like material qualifying the end
product as municipal solid waste (See the comprehensive video on the right).
We believe the product is a game changer in the Regulated Medical Waste space and it has
already begun saving hospitals and clinics millions of dollars by affecting not only how they
handle the often times hazardous waste material, but also in regulatory compliance fees and
reporting requirements.
As we mentioned earlier this weekend, we feel that the potential moves for this equity will make
our now infamous BioElectronics (OTC:BIEL) pick look like child's play. Some of you may
recall that we did help call attention to BIEL's technology at the sub penny level before it moved
to $.12 before stalling and becoming a "buy on rumor sell on news" penny stock. Things may
1 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
change for BIEL if they ever finally get their FDA approval, but even then, the billion shares of
trading float have become a huge anchor to the stock.
Investors who invested in American Scientific Resources, Inc's (Pink Sheets: ASFX) FDA
approved home needle destruction device, the Disintegrator(TM) and Disintegrator Plus(TM)
should also get very excited about this medical waste play. ASFX.PK ran from .003 to .08 based
on a needle dispenser (one product) called the Disintegrator. They traded millions of shares
churning through the shares to get that to the .08 level w/o the transparency of the share
structure.
Another one of our recently profiled companies, Viking Systems, Inc. (OTCBB:VKNG)
recently ran from $.003 to $1.10 on news regarding a contract with the U.S. Army
over a period of four days.
VKNG also appeared on the SEC's
Regulation SHO
compliance tool list (like MCLN does today [more on that below]).
MedClean Technologies, Inc. (OTC: MCLN) looks more bullish and attractive to small cap
investors than any of these other companies, but don't take our word for it. Look at the chart.
Our published report on the company Tuesday will mark the first time any publication or news
portal will call attention to the company and their product. The management team does not
believe in hiring penny-stock pumpers and promoters an have never one so. This will be the first
comprehensive report on the company with quotes and information from the actual
management team.
Here are just a few of the bullet points that will be discussed in more detail in our special report
on Tuesday morning:
- MCLN's stock has just emerged from the sub-penny trading level and our own short-term
trading target of $.40
is based on our own in-depth technical, fundamental and financial analysis of the company.
A six month trading target of $1+ is very much possible
, but not likely sustainable without future growth and reported income variables which may or
may not be part of the company's immediate plans.
2 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
- MCLN has been on the SEC's Regulation SHO compliance tool list for 19 consecutive
days and is now
high on the market maker's
"buyin imminent" list
. In our opinion, continued volume will force the market makers to cover and help fuel prices
during the next 48-72 hours- exploding higher as demand exceeds supply.
- In 2008, MCLN posted a loss of 7.8 million and in the 3rd qrtr of 2009 they were cash flow
positive on an EBIDTA basis. Third Quarter Revenue Increases 108% Year-Over-Year.
- MCLN was recently awared a substantial MedAssets Supply Chain Systems Contract. M
edAssets (Nasdaq: MDAS)
trades at over $23 per share and they partner with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue cycle solutions.
MedAssets serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute
carehealthcare providers.
- Thanks to orders from hospitals and clinics like those, MCLN's management team has
informed us that they are running at full capacity and still experiencing an accumulation of
unfilled orders.
- MCLN's management team helped take their previous company to the NASDAQ and they
identified and protected intellectual property w/ patent application entitled “Containerized
Medical Waste Treatment System and Related Method.” The group previously worked together
at eResearchTechnology, Inc- where they helped grow the company's market valuation from
$27 million to a peak of $1.5 billion, receiving recognition from Fortune Magazine as the number
two fastest growing company in America. They recognized a fantastic new market opportunity
with MCLN and are building that vision now.
While we certainly hope you get as excited as we are about MCLN, we urge you to do your own
research and wish you only the best in your trading and investing.
This report is intended for paid subscribers of BioMedReports. Paid subscriptions are what
monetize BioMedReports, so please be aware that any unauthorized dissemination, review,
distribution or copying of this report is strictly prohibited. We will work with the owners of public
3 / 4
Next Big Mover in Medical Small Caps
Written by M.E.Garza
Sunday, 29 November 2009 15:46 - Last Updated Sunday, 29 November 2009 20:54
forums or websites where this information is posted without permission to provide us with the IP
address an/or identity of any individuals who post this or any other subscription based
information from this site.
Disclosure: Long MCLN

Thanks PMLG. I will keep those on my watch list.

PMLG

What's your target for these XMDC, VKNG & MCLN. I have been watching them since .009, .19 & .005

When I got your alert, it was only 112%. I guess kicking myself won't help lol, but its ok I got CHRI & ISCR.

Thanks much Masked Superstar.

THE WAVE TEAM,

Thanks for the great picks..I got in CHRI @ .014 yesterday when I got the email alert & it is doing great.

I got the the alert about AVMD, but wasn't so sure. They had .02 net per share, how do you determine the value of the stock based on the net income? I am in a learning mode :)

Thanks in advance
Ariki